A Qualitative Analysis of Patient Experiences Using Semaglutide 2.4 mg for Weight Loss
This qualitative analysis of Reddit posts provides valuable insights into the real-world experiences of individuals using semaglutide 2.4 mg for weight management. By understanding these user experiences, healthcare providers can better tailor obesity treatment plans and enhance patient-centered care for those using second-generation anti-obesity medications like semaglutide 2.4 mg.
Authors
- John A. Henry (ORCID: https://orcid.org/0000-0002-7650-0963)
- Jemma Walker (ORCID: https://orcid.org/0000-0003-3728-9509)
- Dhara N. Amin
- Eion Plenn
- Gabrielle Leavitt (ORCID: https://orcid.org/0000-0002-3138-6271)
- Taraneh Soleymani
Institutions
- St. George's University (GD)
- Cooper Medical School of Rowan University (US)
- Geisinger Commonwealth School of Medicine (US)
- Penn State Milton S. Hershey Medical Center (US)
- Temple University (US)
Publication Details
- Journal
- Obesity Science & Practice
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1002/osp4.70085
- Citations
- 1
- Primary Topic
- Obesity and Health Practices
- Type
- article
- Field-Weighted Citation Impact
- 2.02